| Edition |
Fourth edition. |
| Description |
xviii, 655 pages : illustrations ; 24 cm. |
| Series |
Health reference series |
|
Health reference series
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Preface -- Part 1: Introduction To Sexually Transmitted Diseases (STDs) -- 1: Frequently asked questions about (STDs) -- 2: Trends in reportable STDs -- 2-1: Statistics for the most common STDs in the United States -- 2-2: Estimates of new HIV infections in the United States -- 3: STDs in men -- 3-1: STDs among heterosexual men -- 3-2: Methamphetamine use in heterosexual men increases risk of STDs -- 3-3: STDs among men who have sex with men (MSM) -- 3-4: Racial/ethnic and age disparities in Human Immunodeficiency Virus (HIV) among MSM -- 4: STDs in women and children -- 4-1: Pregnancy, infertility, and STDs -- 4-2: Long-term consequences for women and infants with STDs and AIDS -- 4-3: STDs in children and child sexual abuse -- 4-4: Child sexual abuse and long-term HIV prevention -- 5: STDs in teens -- 5-1: Information for teens about STDs -- 5-2: Statistics on STDs in youth -- 5-3: Attitudes of teens toward STDs and sex -- 6: STDs in minorities -- 6-1: Rates of STDs among minorities -- 6-2: Overcoming racial disparities in STDs -- 7: STDs in older patients -- 7-1: Sexual health and aging -- 7-2: HIV, AIDS, and older people -- 7-3: Statistics and concerns about AIDS in older patients -- 8: Substance abuse and STDs -- 8-1: Facts about substance abuse and risky sexual behavior -- 8-2: Substance abuse and HIV/AIDS -- 8-3: HIV prevention in drug-using populations -- Part 2: Preventing Sexually Transmitted Diseases -- 9: Safer sex reduces the risk of STDs -- 10: Barrier methods, contraceptives, and STD prevention -- 10-1: Condoms and female condoms -- 10-2: Other contraceptives and STDs -- 10-3: Hormonal contraception and STD risk -- 11: Oral sex: does it prevent STDs? -- 12: HIV and AIDS prevention -- 12-1: Sex and prevention concerns for people who are HIV positive -- 12-2: Preventing mother-to-child transmission -- 12-3: Preventing HIV transmission among injection drug users -- 12-4: Post-exposure HIV prevention -- 13: Preventing HIV and hepatitis transmission -- 13-1: What health care workers need to know about exposure to blood -- 13-2: Tattoo safety -- 14: Sex education and STD prevention efforts -- 14-1: Discussing STDs with your children -- 14-2: Sex education report -- 14-3: Impact of STD prevention efforts -- Part 3: Types Of Sexually Transmitted Diseases And Their Treatments -- 15: Chancroid -- 16: Chlamydia -- 16-1: Chalmydia overview -- 16-2: Study shows heavy impact of Chlamydia on US men and women -- 17: Cytomegalovirus infection -- 18: Epididymitis -- 19: Gonorrhea -- 19-1: Gonorrhea overview -- 19-2: Gonorrhea missed in screening at STD clinics -- 19-3: Increase in resistant gonorrhea prompts new treatment guidelines -- |
|
20: Viral hepatitis infections -- 20-1: Overview of hepatitis A through E -- 20-2: Rates and risks of HIV and hepatitis co-infection -- 21: Hepatitis B (HBV) -- 21-1: Frequently asked questions about HBV -- 21-2: Pregnancy, children, and HBV -- 21-3: HBV treatment -- 21-4: HBV and liver cancer -- 22: Hepatitis C (HCV) -- 22-1: Facts about HCV infection -- 22-2: Risks of sexual transmission of HCV -- 22-3: Dispelling myths about HCV -- 23: Herpes infections -- 23-1: Genital herpes overview -- 23-2: Oral herpes overview -- 23-3: Herpes complications -- 23-4: Herpes treatment options and vaccine trials -- 24: HIV and AIDS -- 24-1: HIV and AIDS overview -- 24-2: Link between STDs and HIV infection -- 24-3: Understanding your HIV diagnosis -- 24-4: HIV treatment -- 24-5: Medical tests if you have HIV -- 25: Human Papilloma Virus (HPV) and genital warts -- 25-1: HPV overview -- 25-2: Genital warts -- 25-3: HPV and cervical cancer -- 25-4: HPV and oral cancer -- 26: Molluscum contagiosum -- 27: Pelvic inflammatory disease -- 28: Pubic lice (crabs) -- 29: Scabies -- 30: Syphilis -- 30-1: What you should know about syphilis -- 30-2: Syphilis rates on the rise in the United States -- 30-3: Increasing impact of syphilis on MSM, women, and African Americans -- 30-4: Syphilis and HIV/AIDS co-infection -- 31: Trichomoniasis -- 32: Vaginosis caused by bacteria -- 32-1: Understanding bacterial vaginosis -- 32-2: Vaginosis and the risk of AIDS -- 33: Less common STDs and their treatments -- 33-1: Candidiasis (yeast infections) -- 33-2: Granuloma inguinale (Donovanosis) -- 33-3: Lymphogranuloma venereum (LGV) -- 33-4: Nongonococcal urethritis (NGU) -- 33-5: Sexually transmitted intestinal and enteric infections: proctitis, proctocolitis, and enteritis -- Part 4: Testing And Diagnosing Sexually Transmitted Diseases -- 34: Who should get tested for STDs -- 35: Getting tested for STDs if you have been sexually assaulted -- 36: Tests for HIV -- 36-1: HIV testing options -- 36-2: Privacy, insurance, and the cost of HIV testing -- 36-3: Over-the-counter and home test kits for HIV -- |
|
37: Tests for other STDs -- 37-1: Laboratory tests for Chlamydia -- 37-2: Laboratory tests for gonorrhea -- 37-3: Laboratory tests for HBV and HCV -- 37-4: Laboratory test for herpes -- 37-5: Laboratory tests for HPV -- 37-6: Laboratory tests for syphilis -- Part 5: Discussing And Living With Sexually Transmitted Diseases -- 38: Sharing your sexual history -- 39: Talking to your partner about STDs -- 40: Disclosure assistance services -- 41: Revealing your HIV status -- 42: Building a doctor/patient relationship -- 43: Caring for someone with HIV/AIDS -- Part 6: Sexually Transmitted Disease Vaccines And Research -- 44: Overview of significant advances in STD research -- 45: STD vaccines and vaccine research -- 45-1: Vaccines for hepatitis A and B -- 45-2: HPV vaccine and cervical cancer -- 45-3: HPV vaccines for children and state mandates -- 45-4: Possibilities and challenges in the quest for an effective HIV vaccine -- 45-5: Research on preventive HIV vaccines -- 46: Topical microbicides and STDs -- 47: Internet drugs falsely claim to prevent and treat STDs -- 48: Newly developed testing method catches nearly twice as many gonorrhea and Chlamydia infections -- 49: Human protein may offer novel target for blocking HIV infection -- 50: New trials of pre-exposure prophylaxis for HIV prevention -- 51: Research supports early treatment for HIV/AIDS -- Part 6: Additional Help And Information -- 52: Glossary of terms related to STDs -- 53: Directory of STD organizations and resources -- 54: Additional reading about STDs -- Index. |
| Summary |
From the Back Cover: Sexually Transmitted Diseases Sourcebook, Fourth Edition provides updated information about STDs, their symptoms and treatments, and their occurrence in specific groups, such as women, teens, seniors, and homosexuals. It explains treatment and testing options, statistical data, and current research about STD prevention, clinical trials, vaccines, and other medical news. It discusses methods of preventing the spread of STDs, tips for living with STDs, guidelines for disclosing that one has an STD, and suggestions about talking to others about STDs. The book concludes with a glossary of related terms, a directory of resources, and suggestions for further reading. |
| Subject |
Sexually transmitted diseases -- Popular works.
|
|
Sexually Transmitted Diseases -- Popular Works.
|
|
Sexually Transmitted Diseases -- Resource Guides.
|
| Added Author |
Larsen, Laura.
|
| ISBN |
9780780810730 hardcover alkaline paper |
|
0780810732 hardcover alkaline paper |
|
